FOR IMMEDIATE RELEASE:
Chapel Hill, NC – 4 May 2018 – Whitsell Innovations, Inc. to sponsor and attend the 11th Annual Diversity Alliance for Science East Coast Conference
Robin Whitsell, Founder and President of Whitsell Innovations (WI), Inc. and Tom McPhatter, Director, Business Development will be attending the Diversity Alliance for Science (DA4S) East Coast Conference from June 4-6, 2019 in Newark, New Jersey. DA4S will be hosting its three-day event at the Newark Liberty Airport Marriott Hotel.
“We are delighted to sponsor and attend the DA4S meeting,” says WI founder Robin Whitsell. “We appreciate that this organization strives to create relationships between innovative, diverse suppliers and global science organizations. I have been honored to serve the DA4S in furthering this mission.”
This conference will feature government officials, top-level pharmaceutical executives, CEOs of diverse scientific and clinical enterprises, and other guest speakers. Ms. Whitsell is an immediate past Board Member, co-chair of the Mentoring Committee, and a member of the Sponsorship Committee. WI is a also a gold-level sponsor of this meeting.
The mission of Diversity Alliance for Science is to provide a platform to identify, attract, and develop small and diverse businesses to drive inclusive procurement practices in corporate, academic, and governmental entities within the life science and healthcare industries.
ABOUT WHITSELL INNOVATIONS, INC.
WI is a Women’s Business Enterprise National Council (WBENC) certified woman owned full-service medical and scientific writing company headquartered in Chapel Hill, North Carolina.
Contact: info@whitsellinnovations.com
Website: www.whitsellinnovations.com
This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the company’s control. Whitsell Innovations, Inc.’s actual results, performance, or achievements could be materially different from those projected by these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward-looking statements.
###
